Wealthspire Advisors (Maryland)’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
$37K Buy
+13,855
New +$37K ﹤0.01% 477